Nafamostat Mesilate

Cardiovascular Drug ReviewsVolume 13, Issue 1 p. 51-65 Free to Read Nafamostat Mesilate Kenji Okajima, Corresponding Author Kenji Okajima Department of Laboratory Medicine, Kumamoto University Medical School, Kumamoto, JapanAddress correspondence and reprint requests to Dr. K. Okajima at Department of Laboratory Medicine, Kumamoto University Medical School, Honjo 1-1-1, Kumamoto 860, Japan.Search for more papers by this authorMitsuhiro Uchiba, Mitsuhiro Uchiba Department of Medicine, Kumamoto University Medical School, Kumamoto, Japan.Search for more papers by this authorKazunori Murakami, Kazunori Murakami Department of Medicine, Kumamoto University Medical School, Kumamoto, Japan.Search for more papers by this author Kenji Okajima, Corresponding Author Kenji Okajima Department of Laboratory Medicine, Kumamoto University Medical School, Kumamoto, JapanAddress correspondence and reprint requests to Dr. K. Okajima at Department of Laboratory Medicine, Kumamoto University Medical School, Honjo 1-1-1, Kumamoto 860, Japan.Search for more papers by this authorMitsuhiro Uchiba, Mitsuhiro Uchiba Department of Medicine, Kumamoto University Medical School, Kumamoto, Japan.Search for more papers by this authorKazunori Murakami, Kazunori Murakami Department of Medicine, Kumamoto University Medical School, Kumamoto, Japan.Search for more papers by this author First published: March 1995 https://doi.org/10.1111/j.1527-3466.1995.tb00213.xCitations: 33AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume13, Issue1March 1995Pages 51-65 RelatedInformation